News

A team of Texas A&M University NPs, nursing students, and a Spanish-speaking community health worker work together to ...
European Commission Approves Biocon Biologics’ Denosumab BiosimilarsBengaluru, Karnataka, India, July 3, 2025 Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary ...
Session Type: E-Poster Poster No.: 145eTiP About Anixa Biosciences, Inc. Anixa is a clinical-stage biotechnology company focused on the treatment and prevention of cancer.
Ben Phua struggles with burnout caring for his special needs son but wants the best for him. Read more at straitstimes.com. Read more at straitstimes.com.
Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix ®), a life sciences innovator, manufacturer, and exporter, announces that it is attending and presenting at the 2nd Asia Pacific Conference ...
At a Brown University symposium hosted by Rhode Island’s federally funded IDeA programs, biomedical scientists shared how ...
Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced poster presentations on investigational ND0612 in Parkinson's disease (PD) will be shared at the 11 th Congress of the European Academy of ...
In Philadelphia , the leading causes of death are heart disease, cancer and unintentional drug overdose. While some of these deaths are caused by thi ...
President Fujimori’s sterilisation drive killed a woman in the 1990s. Her trial shows democracy is again backsliding ...
autoimmunity and cancer, including TNX-1500, which is an Fc-modified humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and ...
HHS will renew funding to states for cancer prevention and tracking efforts, alleviating anxieties among local officials ...